Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.09
+0.10 (1.25%)
Feb 5, 2025, 10:54 AM EST - Market open
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.51 billion as of February 5, 2025. Its market cap has increased by 54.00% in one year.
Market Cap
2.51B
Enterprise Value
5.04B
1-Year Change
54.00%
Ranking
Category
Stock Price
$8.09
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.51B, a decrease of -56.48%. That is a compound annual growth rate of -11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2025 | 2.53B | 3.28% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.82B |
| UnitedHealth Group | 501.97B |
| Johnson & Johnson | 369.55B |
| Novo Nordisk | 365.99B |
| AbbVie | 335.67B |
| Merck & Co. | 229.54B |
| Abbott Laboratories | 223.92B |
| Thermo Fisher Scientific | 222.07B |